187 related articles for article (PubMed ID: 6088026)
41. Neuron-specific enolase in the pituitary gland.
Van Noorden S; Polak JM; Robinson M; Pearse AG; Marangos PJ
Neuroendocrinology; 1984 Apr; 38(4):309-16. PubMed ID: 6374489
[TBL] [Abstract][Full Text] [Related]
42. Pretreatment Levels of Chromogranin A and Neuron-specific Enolase in Patients With Gastroenteropancreatic Neuroendocrine Neoplasia.
Kečkéš Š; Palaj J; Waczulíková I; Dyttert D; Mojtová E; Kováč G; Durdík Š
In Vivo; 2021; 35(5):2863-2868. PubMed ID: 34410979
[TBL] [Abstract][Full Text] [Related]
43. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers.
Bergh J; Esscher T; Steinholtz L; Nilsson K; Påhlman S
Am J Clin Pathol; 1985 Jul; 84(1):1-7. PubMed ID: 2409790
[TBL] [Abstract][Full Text] [Related]
44. Enolase subunits in patients with neuroendocrine tumors.
Iwase K; Nagasaka A; Kato K; Ohtani S; Nagatsu I; Ohyama T; Nakai A; Aono T; Nakagawa H; Shinoda S
J Clin Endocrinol Metab; 1986 Jul; 63(1):94-101. PubMed ID: 3519652
[TBL] [Abstract][Full Text] [Related]
45. Chromogranin A and neuron-specific enolase as prognostic markers in patients with advanced pNET treated with everolimus.
Yao JC; Pavel M; Phan AT; Kulke MH; Hoosen S; St Peter J; Cherfi A; Öberg KE
J Clin Endocrinol Metab; 2011 Dec; 96(12):3741-9. PubMed ID: 21994954
[TBL] [Abstract][Full Text] [Related]
46. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
Nisman B; Heching N; Biran H; Barak V; Peretz T
Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of serum neuron-specific enolase as a tumor marker for carcinoma of the lung.
Ariyoshi Y; Kato K; Ishiguro Y; Ota K; Sato T; Suchi T
Gan; 1983 Apr; 74(2):219-25. PubMed ID: 6305752
[TBL] [Abstract][Full Text] [Related]
48. Electron-immunocytochemical localization of neuron-specific enolase in cytoplasm and on membranes of primary and metastatic cerebral tumours and on glial filaments of glioma cells.
Vinores SA; Herman MM; Rubinstein LJ
Histopathology; 1986 Sep; 10(9):891-908. PubMed ID: 3536714
[TBL] [Abstract][Full Text] [Related]
49. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study].
Eberlein-Gonska M; Wiedenmann B; Waldherr R
Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534
[No Abstract] [Full Text] [Related]
50. Neuroendocrine differentiation in stage D2 prostate cancers.
Kamiya N; Suzuki H; Kawamura K; Imamoto T; Naya Y; Tochigi N; Kakuta Y; Yamaguchi K; Ishikura H; Ichikawa T
Int J Urol; 2008 May; 15(5):423-8. PubMed ID: 18452460
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical and ultrastructural analysis of bronchopulmonary neuroendocrine neoplasms. I. Carcinoids.
Warren WH; Memoli VA; Gould VE
Ultrastruct Pathol; 1984; 6(1):15-27. PubMed ID: 6375057
[TBL] [Abstract][Full Text] [Related]
52. The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavage.
Prados MC; Alvarez-Sala R; Blasco R; Chivato T; García Satué JL; García Río FJ; Gómez de Terrero FJ; Villamor J
Cancer; 1994 Sep; 74(5):1552-5. PubMed ID: 8062188
[TBL] [Abstract][Full Text] [Related]
53. Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
Schmitt UM; Stieber P; Hasholzner U; Pahl H; Hofmann K; Fateh-Moghadam A
Eur J Clin Chem Clin Biochem; 1996 Aug; 34(8):679-82. PubMed ID: 8877347
[TBL] [Abstract][Full Text] [Related]
54. Development of a radioimmunoassay for neurone specific enolase (NSE) and its application in the study of patients receiving intra hepatic arterial streptozotocin and floxuridine.
Cunningham RT; Johnston CF; Irvine GB; McIlrath EM; McNeill A; Buchanan KD
Clin Chim Acta; 1990 Aug; 189(3):275-86. PubMed ID: 2146046
[TBL] [Abstract][Full Text] [Related]
55. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
56. [Neuron-specific enolase in bronchial carcinoma. Immunohistochemical and immunoenzyme study].
Leonardo E; Dogliotti C; Oliaro A
Minerva Med; 1986 May; 77(22-23):977-80. PubMed ID: 3014380
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemistry of neuron-specific enolase in neurons of the medulla oblongata from human autopsies.
Nogami M; Takatsu A; Endo N; Ishiyama I
Acta Histochem; 1998 Nov; 100(4):371-82. PubMed ID: 9842417
[TBL] [Abstract][Full Text] [Related]
58. Neuron specific enolase demonstration in the diagnosis of a solid-cystic (papillary cystic) tumour of the pancreas.
Chott A; Klöppel G; Buxbaum P; Heitz PU
Virchows Arch A Pathol Anat Histopathol; 1987; 410(5):397-402. PubMed ID: 3103322
[TBL] [Abstract][Full Text] [Related]
59. Immunohistochemical staining of granular cell tumour for neurone specific enolase: evidence in support of a neural origin.
Rode J; Dhillon AP; Papadaki L
Diagn Histopathol; 1982; 5(3):205-11. PubMed ID: 6183084
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical study of malignant melanoma.
Hirano T
Acta Pathol Jpn; 1986 May; 36(5):733-43. PubMed ID: 3526811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
